Biofil Chemicals & Pharmaceuticals Shareholding Pattern
- Market cap
- ₹49.7 crore
- P/E
- 102.7
- P/B
- 2.30
- ROE
- 13.8%
- Dividend yield
- 1.20%
As of 30-JUN-2026, promoters held 46.79% of Biofil Chemicals & Pharmaceuticals (0.00 pp from 31-MAR-2026), domestic institutions 0.08% and the public 53.13%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.
Biofil Chemicals & Pharmaceuticals shareholding pattern — frequently asked questions
What is the promoter holding in Biofil Chemicals & Pharmaceuticals?
Promoters held 46.79% of Biofil Chemicals & Pharmaceuticals as of 30-JUN-2026, unchanged from 46.79% in 31-MAR-2026.
How much do domestic institutions hold in Biofil Chemicals & Pharmaceuticals?
Domestic institutional investors, including mutual funds and insurers, held 0.08% of Biofil Chemicals & Pharmaceuticals as of 30-JUN-2026 (0.00 pp from the previous quarter).
Who owns Biofil Chemicals & Pharmaceuticals?
As of 30-JUN-2026, Biofil Chemicals & Pharmaceuticals' shareholders were promoters (46.79%), domestic institutions 0.08% and the public 53.13%, as filed with the stock exchanges.
Same Data For Peers
Trade Biofil Chemicals & Pharmaceuticals With ATS
Track BIOFILCHEM live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.